Results 41 to 50 of about 2,033,277 (389)
COVID‐19 in kidney transplant recipients: A multicenter experience in Istanbul
Transplant Infectious Disease, 2020 Management of COVID‐19 in kidney transplant recipients should include treatment of the infection, regulation of immunosuppression, and supportive therapy. However, there is no consensus on this issue yet.
E. Demir +17 more
semanticscholar +1 more source
Predicting Dosage of Immunosuppressant Drugs After Kidney Transplantation Using Machine Learning [PDF]
arXiv, 2023 While kidney transplants are seen as the best treatment option for patients with end-stage renal disease and kidney failure, the organ's health depends on the dosage of immunosuppressant drugs post-transplantation. Due to the dosage variance based on each patient's unique physiology, nephrologists face numerous difficulties when determining the precise
arxiv
Obesity in Kidney Transplantation [PDF]
Journal of Renal Nutrition, 2014 Kidney transplantation is the preferred modality of renal replacement therapy. Long-term patient and graft survival have only improved marginally over the recent decade, mainly because of the development of cardiovascular disease after transplantation.
Philip G. McTernan +6 more
openaire +5 more sources
Evaluation of transplant benefits with the U.S. Scientific Registry of Transplant Recipients by semiparametric regression of mean residual life [PDF]
arXiv, 2023 Kidney transplantation is the most effective renal replacement therapy for end stage renal disease patients. With the severe shortage of kidney supplies and for the clinical effectiveness of transplantation, patient's life expectancy post transplantation is used to prioritize patients for transplantation; however, severe comorbidity conditions and old ...
arxiv
COVID‐19 in an HIV‐positive kidney transplant recipient
Transplant Infectious Disease, 2020 We report a case of a 50‐year‐old male with a history of HIV and kidney transplant who presented with SARS‐CoV‐2. We also present a review of COVID‐19 cases in kidney transplant recipients.
Rebecca N. Kumar +3 more
semanticscholar +1 more source
Renal Replacement Therapy, 2018 Background In the patients with severe atherosclerotic renal artery stenosis (ARAS), the evaluation of long-term clinical outcome after percutaneous transluminal renal angioplasty (PTRA) has yet been insufficient.
Yasuhiro Mochida +9 more
doaj +1 more source
Predicting Kidney Transplant Survival using Multiple Feature Representations for HLAs [PDF]
Proceedings of the 19th International Conference on Artificial
Intelligence in Medicine (2021) 51-60, 2021 Kidney transplantation can significantly enhance living standards for people suffering from end-stage renal disease. A significant factor that affects graft survival time (the time until the transplant fails and the patient requires another transplant) for kidney transplantation is the compatibility of the Human Leukocyte Antigens (HLAs) between the ...
arxiv
Complement in Kidney Transplantation [PDF]
Frontiers in Medicine, 2017 The complement system is considered to be an important part of innate immune system with a significant role in inflammation processes. The activation can occur through classical, alternative, or lectin pathway, resulting in the creation of anaphylatoxins C3a and C5a, possessing a vast spectrum of immune functions, and the assembly of terminal ...
Marek Cernoch +2 more
openaire +4 more sources
BMC Infectious Diseases, 2019 Background Trimethoprim-sulfamethoxazole (TMP-SMX) is the drug of choice for anti-Pneumocystis jirovecii pneumonia (PcP) prophylaxis in kidney transplant recipients (KTR).
G. V. Ramesh Prasad +7 more
doaj +1 more source
Metabolic evaluation of high-risk stone formers: a retrospective study
African Journal of Urology, 2023 Background The purpose of this study was to assess the metabolic abnormalities in high-risk stone formers. Methods This was a retrospective observational study done at Tribhuvan University Teaching Hospital, Nepal, over 1-year period.
Purushottam Parajuli +7 more
doaj +1 more source